Works matching DE "ANTISENSE drugs"
Results: 38
Silencing human genetic diseases with oligonucleotide-based therapies.
- Published in:
- Human Genetics, 2013, v. 132, n. 5, p. 481, doi. 10.1007/s00439-013-1288-1
- By:
- Publication type:
- Article
Antisense-based therapy for the treatment of spinal muscular atrophy.
- Published in:
- Journal of Cell Biology, 2012, v. 199, n. 1, p. 21, doi. 10.1083/jcb.201207087
- By:
- Publication type:
- Article
Antisense Therapy in Neurology.
- Published in:
- Journal of Personalized Medicine, 2013, v. 3, n. 3, p. 144, doi. 10.3390/jpm3030144
- By:
- Publication type:
- Article
Expression of Amiloride-sensitive Epithelial Sodium Channels in Mouse Taste Cells after Chorda Tympani Nerve Crush.
- Published in:
- Chemical Senses, 2005, v. 30, n. 6, p. 531, doi. 10.1093/chemse/bji046
- By:
- Publication type:
- Article
Intravesical Liposome and Antisense Treatment for Detrusor Overactivity and Interstitial Cystitis/Painful Bladder Syndrome.
- Published in:
- ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/601653
- By:
- Publication type:
- Article
Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-α in murine herpes simplex virus type 1 retinitis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2012, v. 250, n. 2, p. 231, doi. 10.1007/s00417-011-1840-4
- By:
- Publication type:
- Article
CLIFinder: identification of LINE-1 chimeric transcripts in RNA-seq data.
- Published in:
- Bioinformatics, 2018, v. 34, n. 4, p. 688, doi. 10.1093/bioinformatics/btx671
- By:
- Publication type:
- Article
Cure Hunter to Treat Marfan Syndrome; Introducing New Remedies to Target Transforming Growth Factor- Beta (TGF-β).
- Published in:
- Journal of Pakistan Medical Students, 2013, v. 3, n. 1, p. 28
- By:
- Publication type:
- Article
Antagonism of miRNA in heart failure: first evidence in human.
- Published in:
- European Heart Journal, 2021, v. 42, n. 2, p. 189, doi. 10.1093/eurheartj/ehaa967
- By:
- Publication type:
- Article
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.
- Published in:
- European Heart Journal, 2021, v. 42, n. 2, p. 178, doi. 10.1093/eurheartj/ehaa898
- By:
- Publication type:
- Article
Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.
- Published in:
- Renal Failure, 2013, v. 35, n. 10, p. 1418, doi. 10.3109/0886022X.2013.828309
- By:
- Publication type:
- Article
FXI-ASO May Represent a New Class of Antithrombotic Agents.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 10, doi. 10.1177/1559897714568644
- By:
- Publication type:
- Article
In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120058
- By:
- Publication type:
- Article
Modified Oligonucleotides: Strides towards Antisense Drugs.
- Published in:
- Trends in Carbohydrate Research, 2013, v. 5, n. 3, p. 1
- By:
- Publication type:
- Article
Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear.
- Published in:
- Psychopharmacology, 2015, v. 232, n. 20, p. 3809, doi. 10.1007/s00213-015-4042-7
- By:
- Publication type:
- Article
Functional correction by antisense therapy of a splicing mutation in the GALT gene.
- Published in:
- European Journal of Human Genetics, 2015, v. 23, n. 4, p. 500, doi. 10.1038/ejhg.2014.149
- By:
- Publication type:
- Article
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2.
- Published in:
- European Journal of Human Genetics, 2013, v. 21, n. 7, p. 769, doi. 10.1038/ejhg.2012.261
- By:
- Publication type:
- Article
Synthesis of Methoxyethyl Nucleoside Dimer Phosphoramidites.
- Published in:
- Bulletin of the Korean Chemical Society, 2016, v. 37, n. 5, p. 667, doi. 10.1002/bkcs.10749
- By:
- Publication type:
- Article
Viral therapeutics: Antisense therapy makes sense for HCV.
- Published in:
- Nature Reviews Microbiology, 2013, v. 11, n. 5, p. 301, doi. 10.1038/nrmicro3022
- By:
- Publication type:
- Article
Molecular imaging and pharmacokinetics of <sup>99m</sup>Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 2, p. 97, doi. 10.1002/jlcr.3171
- By:
- Publication type:
- Article
Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon Skipping.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 3, p. 580, doi. 10.1038/mt.2011.264
- By:
- Publication type:
- Article
Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats.
- Published in:
- Archives of Toxicology, 2012, v. 86, n. 3, p. 453, doi. 10.1007/s00204-011-0761-7
- By:
- Publication type:
- Article
Regulatory watch: Antisense approval provides boost to the field.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 179, doi. 10.1038/nrd3963
- By:
- Publication type:
- Article
Antisense oligonucleotide to treat a rare hereditary disease.
- Published in:
- Medical Writing, 2018, v. 27, n. 3, p. 49
- By:
- Publication type:
- Article
Biotech comes to its 'antisenses' after hard-won drug approval.
- Published in:
- Nature Medicine, 2013, v. 19, n. 3, p. 252, doi. 10.1038/nm0313-252
- By:
- Publication type:
- Article
Hopes soar as cholesterol plummets with new drug class.
- Published in:
- Nature Medicine, 2012, v. 18, n. 5, p. 633, doi. 10.1038/nm0512-633
- By:
- Publication type:
- Article
A population pharmacokinetic meta-analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 9, p. 1932, doi. 10.1111/bcp.13287
- By:
- Publication type:
- Article
Clinical pharmacological properties of mipomersen ( Kynamro), a second generation antisense inhibitor of apolipoprotein B.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 269, doi. 10.1111/j.1365-2125.2012.04469.x
- By:
- Publication type:
- Article
Sequential Gene Silencing Using Wavelength-Selective Caged Morpholino Oligonucleotides.
- Published in:
- Angewandte Chemie, 2014, v. 126, n. 38, p. 10278, doi. 10.1002/ange.201405355
- By:
- Publication type:
- Article
In vivo uptake of antisense oligonucleotide drugs predicted by ab initio quantum mechanical calculations.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85453-6
- By:
- Publication type:
- Article
Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 6, p. 717, doi. 10.1111/apt.13526
- By:
- Publication type:
- Article
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 9, p. 850, doi. 10.1111/apt.12051
- By:
- Publication type:
- Article
MiR-377 Mediates the Effect of Syk on Atherosclerosis in ApoE-/- Mice.
- Published in:
- Journal of Hainan Medical University, 2020, v. 26, n. 2, p. 17
- By:
- Publication type:
- Article
Targeting Eukaryotic Translation in Mesothelioma Cells with an eIF4E-Specific Antisense Oligonucleotide.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081669
- By:
- Publication type:
- Article
Preparation of 5′-O-(1-Thiotriphosphate)-Modified Oligonucleotides Using Polymerase-Endonuclease Amplification Reaction (PEAR).
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067558
- By:
- Publication type:
- Article
Celgene shells out for antisense drug.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 605, doi. 10.1038/nbt0714-605b
- By:
- Publication type:
- Article
Antisense battles small molecule for slice of rare lipid disorder market.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 179, doi. 10.1038/nbt0313-179
- By:
- Publication type:
- Article
Isis inks two antisense deals.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 91, doi. 10.1038/nbt0213-91a
- By:
- Publication type:
- Article